These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4141670)

  • 1. [Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
    Ikeda H; Imai Y; Uchimura H; Matsuzaki F; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):408. PubMed ID: 4141670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):409. PubMed ID: 4141671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolution of thyroximemia in the course of Basedow's disease treated with thyroid antagonists].
    Linquette M; Fossati P; Decoulx M; Racadot A; Benoit G; Asfour M
    Lille Med; 1977 Oct; 22(8):489-94. PubMed ID: 73116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basedow's disease in the pregnant woman. Should thyroxine be added to synthetic antithyroid drugs?].
    Lutz P
    Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 62341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperthyreosis in Basedow's disease].
    Välimäki MJ
    Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basedow's disease].
    Kumahara Y
    Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
    [No Abstract]   [Full Text] [Related]  

  • 7. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basedow's disease. 1. Drug therapy of hyperthyroidism].
    Tourniaire J
    Lyon Med; 1971; 18():Suppl:48-51. PubMed ID: 4105819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inorganic iodine treatment of Basedow's disease].
    Nagataki S; Uchimura H
    Horumon To Rinsho; 1974 Feb; 22(2):231-8. PubMed ID: 4407980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J; Jaffiol C; Baldet L; Ghachem M
    Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of iodotherapy in the medical treatment of Basedow's disease].
    Gilbert-Dreyfus
    Therapeutique; 1971 Apr; 47(4):347-9. PubMed ID: 4105094
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R
    MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Basedow's disease].
    Bürgi H
    Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of T3-predominant Graves' disease].
    Lin LX
    Zhonghua Yi Xue Za Zhi; 1988 Feb; 68(2):79-81. PubMed ID: 2457417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current concepts in the treatment of Basedow's disease].
    Jaffiol C; Baldet L
    Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basedow's disease].
    Shizume K
    Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basedow's disease: surgery, the choice treatment].
    Chiampo L
    Minerva Endocrinol; 1987; 12(1):49-53. PubMed ID: 2438548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
    Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
    Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.